MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-06-0004773
Bhavyas Pharmaceuticals Private Limited
Bhavyas Pharmaceuticals Private Limited - pharma in Medak, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.83 Cr
▼ 11% YoY
Net profit · FY 2025
₹17.9 Lakh
Net margin 6.3%
EBITDA · FY 2025
₹38.29 Lakh
EBITDA margin 13.6%
Authorised capital
₹2.2 Cr
Registered with MCA
Paid-up capital
₹2.15 Cr
Issued & subscribed
Open charges
₹1.14 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Employees · EPFO
8
Provident fund records
About Bhavyas Pharmaceuticals Private Limited
Data last updated:
Bhavyas Pharmaceuticals Private Limited is a private limited company based in Medak, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2019PTC132290. Its GSTIN is 36AAICB4122H1ZX (Telangana).
The company has an authorised share capital of ₹2.2 Cr and a paid-up capital of ₹2.15 Cr. It is led by directors including Naresh Ponduri and Anji Reddy Nandipati.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Medak, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.83 Cr, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹17.9 Lakh (net margin 6.3%) and EBITDA of ₹38.29 Lakh (EBITDA margin 13.6%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years.
The company has about 8 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.14 Cr on record.
Bhavyas Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-06-0004773). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24239TG2019PTC132290
Registration Number 132290
Incorporation Date 25 April 2019
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-06-0004773
Recognitions & Rankings of Bhavyas Pharmaceuticals
Contact details
Bhavyas Pharmaceuticals Private Limited's registered office is in Medak, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSurvey No.367 A/1 367 A/3 Peddagotti Mukkala Village Sivampet Man, Dal, Medak, Telangana, India – 502334
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bhavyas Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Bhavyas Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Bhavyas Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Bhavyas Pharmaceuticals Private Limited, buy the company report.
Financials of Bhavyas Pharmaceuticals Private Limited
FY 2024 filings availableBhavyas Pharmaceuticals Private Limited reported revenue of ₹2.83 Cr (down 11% YoY) for FY 2025.
Revenue · FY 2025
₹2.83 Cr ▼ 11%
Net profit · FY 2025
₹17.9 Lakh margin 6.3%
EBITDA · FY 2025
₹38.29 Lakh margin 13.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 11%
3 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 25%
3 years · compounded
▲ 167%
Revenue fell 11% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 17%. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹38.29 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.9 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.6% | ||||
| Net Profit Margin | 6.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bhavyas Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bhavyas Pharmaceuticals Private Limited
Bhavyas Pharmaceuticals has 5 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naresh Ponduri | Director | 25 Apr 2019 | 7 Years 6 Months | Current |
| Anji Reddy Nandipati | Director | 25 Apr 2019 | 7 Years 6 Months | Current |
| Samba Sivarao Arigela | Director | 01 Aug 2023 | 3 Years 3 Months | Current |
| Mandepudi Kirankumar Also directs: MSK Bizzon Private Limited | Director | 20 Nov 2025 | 0 Years 11 Months | Current |
| Subhani Sheik Also directs: Aion Pharma LLP | Director | 20 Nov 2025 | 0 Years 11 Months | Current |
Peer comparison
Bhavyas Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Parry Pharma Private Limited | ₹2.83 Cr (FY 2025) | 23.0% | Ahmedabad, Gujarat, India | |||
| Sabhika Pharmaceuticals Private Limited | ₹2.83 Cr (FY 2025) | 218.0% | Bangalore, Karnataka, India | |||
| Bhavyas Pharmaceuticals Private Limitedthis company | ₹2.83 Cr (FY 2025) | ₹17.9 Lakh | 6.3% | -11.0% | 8 | Medak, Telangana, India |
| Synaptics Pharmaceuticals Private Limited | ₹2.82 Cr (FY 2024) | -36.0% | Hyderabad, Telangana, India | |||
| Ayurprakash Herbal Private Limited | ₹2.82 Cr (FY 2025) | 12.0% | New Delhi, Delhi, India |
To see the full peer comparison of Bhavyas Pharmaceuticals Private Limited, buy the company report.
Auditor
Bhavyas Pharmaceuticals Private Limited is audited by RAMIREDDY H R N V VISWANATH for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAMIREDDY H R N V VISWANATH | FY 2023 | 247587 |
Shareholding
The shareholding of Bhavyas Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Bhavyas Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.14 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Jan 2025 | 101033703 | Others | ₹14.26 Lakh | Open | |
| 22 Oct 2024 | 101005750 | Others | ₹1 Cr | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Bhavyas Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bhavyas Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Bhavyas Pharmaceuticals Private Limited has a workforce of 8 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
Employee count
8
Active EPFO establishments
1
Employee growth
33.33%
GST
Bhavyas Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICB4122H1ZX | Telangana | Active | 05 Jul 2019 |
To see the full GST registrations and return filing status of Bhavyas Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bhavyas Pharmaceuticals Private Limited has 5 board changes on record since 2019: 5 appointments. The latest: Mandepudi Kirankumar was appointed as Director on 20 Nov 2025.
Appointed
Mandepudi Kirankumar was appointed as Director.
Appointed
Subhani Sheik was appointed as Director.
Charges
A charge with Others amounted to Rs. 0.14 Cr with Charge ID 101033703 was registered on 07 Jan 2025.
Charges
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 101005750 was registered on 22 Oct 2024.
AGM
Bhavyas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Bhavyas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Appointed
Samba Sivarao Arigela was appointed as Director.
Appointed
Anji Reddy Nandipati was appointed as Director.
Appointed
Naresh Ponduri was appointed as Director.
Incorporation
25 Apr 2019
Bhavyas Pharmaceuticals Private Limited was registered on 25 Apr 2019 with Roc Hyderabad & aged 7 years 6 months as per MCA records.
Frequently asked questions
Bhavyas Pharmaceuticals is an active private limited company based in Medak, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 April 2019 (7+ years old) and is registered under CIN U24239TG2019PTC132290.
Bhavyas Pharmaceuticals has 5 current directors:
- Naresh Ponduri - Director
- Anji Reddy Nandipati - Director
- Samba Sivarao Arigela - Director
- Mandepudi Kirankumar - Director
- Subhani Sheik - Director
The latest financial statements of Bhavyas Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Bhavyas Pharmaceuticals is 36AAICB4122H1ZX, registered in Telangana.
The CIN (Corporate Identification Number) of Bhavyas Pharmaceuticals is U24239TG2019PTC132290. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bhavyas Pharmaceuticals was incorporated on 25 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Bhavyas Pharmaceuticals by revenue are Parry Pharma Private Limited, Sabhika Pharmaceuticals Private Limited, Synaptics Pharmaceuticals Private Limited, Ayurprakash Herbal Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mandepudi Kirankumar was appointed as Director on 20 Nov 2025. Subhani Sheik was appointed as Director on 20 Nov 2025. Samba Sivarao Arigela was appointed as Director on 01 Aug 2023. Bhavyas Pharmaceuticals has 5 board changes on record in total.
Yes, Bhavyas Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-06-0004773).
The registered office of Bhavyas Pharmaceuticals is at Survey No.367 A1 367 A3 Peddagotti Mukkala Village Sivampet Man, Dal, Medak, Telangana, India – 502334.
Bhavyas Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages